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Abstract
Purpose of Review Stroke is the most feared complication of atrial fibrillation. To prevent stroke, left atrial appendage exclusion
has been targeted, as it is the prevalent site for formation of heart thrombi during atrial fibrillation.
We review the historic development of methods for exclusion of the left atrial appendage and the evidence to support its
amputation during routine cardiac surgery.
Recent Findings Evidence is not yet sufficient to routinely recommend left atrial exclusion during heart surgery, despite a high
prevalence of postoperative atrial fibrillation. Observational studies indicate that electrical isolation of scarring from clip or suture
techniques reduces the arrhythmogenic substrate.
Summary Randomized studies comparing different methods of closure of the left atrial appendage before amputation do not
exist. Such studies are therefore warranted, as well as studies that can elucidate whether amputation is superior to leaving the left
atrial appendage stump. Potentially, thrombogenic remaining pouch after closure should be addressed.
Keywords Left atrial appendage . Cardiac surgery . Atrial fibrillation . Thromboembolism . Stroke
Abbreviations
AF Atrial fibrillation
LA Left atrium
LAA Left atrial appendage
OAC Oral anti-coagulants
TEE Trans-esophageal echocardiography
Introduction
Does left atrial appendage (LAA) amputation during routine
cardiac surgery reduce the risk of stroke and future atrial fi-
brillation? This question has been posed for more than
150 years [1, 2], since the LAA is recognized as the prevalent
site for formation of thrombi during atrial fibrillation (AF)
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[3–5], with stroke being its most common and potentially
devastating thromboembolic complication.
Atrial Fibrillation and Its Relation to Open-heart
Surgery
Occurrence of AF following cardiac surgery is common, with
a prevalence of 10 to 65% [6–8], and is associated with
prolonged hospitalization and higher risk of mortality [7–10].
Paroxysmal AF after cardiac surgery is often self-limiting
[11], and up to 40% of patients with AF are asymptomatic
during the arrhythmia [12]. Hence, many patients with unrec-
ognized recurrent AF, who do not receive anti-coagulation
after surgery, remain at risk for stroke [13]. This is a growing
problem since more elderly patients undergo cardiac surgery
[14]. Although the risk of complications during surgery is
improving, patients continue to have a high risk of stroke if
they have AF [15, 16]. Therefore, multiple approaches are
targeted to relieve this burden. That is, to prevent the occur-
rence of AF [17, 18] and its recurrence after surgery [19–21],
and, to reduce the thrombogenic substrate, the left atrial ap-
pendage (LAA) is excluded [22–24]. Oral anti-coagulation
(OAC) is an efficient method for thromboembolism risk re-
duction [25]. However, the adequate length of OAC after post-
operative AF is still unknown [18, 26]. Importantly, between
30 and 50% of patients are not eligible for OAC due to high
risk of bleeding or other contraindications [25, 27].
Furthermore, it is estimated that 16–50% of patients in OAC
therapy are not sufficiently anti-coagulated [28–30]. In these
patients a highly reliable LAA occlusion would be an attrac-
tive alternative as it potentially reduces stroke risk by 50%
[31].
The Left Atrial Appendage and Thrombus Formation
The LAA is a hook-like diverticulum of the left atrium (LA)
consisting of one or more lobes with a trabeculated wall due to
parallel-running pectinate muscles [32, 33]. In sinus rhythm,
the LAA is highly contractile (contracts from its apex toward
the base) and the blood flow within the lumen is sufficient to
avoid thrombus formation. Contrarily, during AF, the contrac-
tility of the LAA is limited and the blood flow within the
lumen is reduced creating a hemodynamic ‘dead-space’ [34,
35]. Furthermore, the highly trabeculated wall of the LAA
plays an important role in its high thrombogenicity, and in-
creased thrombus formation occurs with smaller LAA orifice
and higher number of lobes [36, 37]. Therefore, the LAA is
considered the primary source of cardio-embolic stroke in
patients with non-valvular AF [25, 38], although thrombi
can develop outside the LAA [3]. Accordingly, transesopha-
geal echocardiography (TEE) is the key examination for diag-
nosing thrombus formation in the LAA [35, 37, 39], and direct
current conversion to sinus rhythm has proved to be safe in the
absence of thrombi in the LAA during TEE [33, 34, 40–42].
Historic Perspective on Amputation of the Left Atrial
Appendage During Surgery
The first amputations of the LAA in humans [43] were report-
ed almost simultaneously with the results of the procedure in
animal experiments [44–46]. After these successful
pioneering attempts, they were subsequently performed in ad-
dition to mitral commissurotomy, to alleviate the well-known
high thrombogenicity in mitral stenosis [38, 47, 48].
Systematic exclusion of the LAA is currently recommended
in addition to surgical ablation procedures [21].
Thoracoscopic amputations of the LAAwere initially per-
formed by Johnson et al. as a stand-alone procedure in patients
with high risk for thromboembolisms, who do not tolerate
OAC [25]. Since then, there have been developed minimally
invasive approaches to amputate the LAA [19, 49–53].
Nevertheless, the development of safe and effective clip de-
vices for obliteration of the LAA thoracoscopically [54] and
intra-operatively [55••, 56], is emerging as a preferred method
compared to LAA amputation [57, 58].
Less Arrhythmogenic Substrate After LAA Exclusion
Persistent AF can originate from the LAA [59] and it has been
demonstrated that targeting ablation of the LAA can reduce
AF [21, 60]. Therefore, exclusion of the LAA can possibly
provide an anti-arrhythmogenic effect, in addition to protec-
tion against thromboembolisms. Accordingly, a reduction of
atrial dispersion has been demonstrated with LAA ligation in
patients with AF [61]. Additionally, clip occlusion [62] and
epicardial ligation [63] have shown to provide electric ap-
pendage isolation. In a recent study, patients randomized to
closure or not closure of the LAA during cardiac surgery,
closure by epicardial suture seemed to reduce AF during
follow-up (Park-Hansen in press). It is conceivable that am-
putation of the LAA can have a similar anti-arrhythmogenic
effect, but such an effect remains to be studied.
Hemodynamic Consequences of LAA Amputation
Natriuretic hormones can be secreted from all myocytes but,
in normal healthy conditions they are primarily produced in
the LAA [64–67]. Levels of natriuretic hormones are elevated
in permanent AF [68] and, specially, levels of B-type natri-
uretic peptide reveal paroxysms after ablation [69–73].
The first successful LAA amputations on healthy dogs in
the 1940s [1] were followed by concerns on possible impair-
ment of mechanisms to compensate fluid overload, due to the
loss of atrium natriuretic peptides and a reduced stroke vol-
ume of the left atrium [44–46]. Despite these concerns,
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experimental observations in animals do not seem to have
clinical importance in humans [74].
Recently, it has been raised concern by the observation that,
along with a decrease on the left atrium volume that follows
successful AF ablation, there is an increase in the LAA vol-
ume, assessed with magnetic resonance scanning [75]. This is
a matter of concern, since larger LAA volume increases the
risk of stroke in patients with comparable thromboembolic
risk profile [76, 77].
In a recent study, no hemodynamic changes have been
observed immediately after percutaneous LAA closure [78].
Nevertheless, it seems to be important whether the LAA is
closed from the endocardial or from the epicardial site, since
comparing the two approaches, only the epicardial closure
proved beneficial hemodynamic changes [79].
According to these observations, an epicardial closure,
with or without subsequent amputation, should be the pre-
ferred approach.
Thrombogenicity After Amputation of the LAA
The thrombogenicity of the LAA during AF is, in part, attrib-
utable to loss of contractility of the LAA. In a retrospective
study of patients who underwent occlusion of the LAA, those
with preserved LAA had a better contractility estimated with
echocardiography, compared with a group where the LAA
was amputated; however, this difference did not preclude dif-
ferences on stroke nor occurrence of AF [80].
Regardless of the LAA exclusion method, the potential
thrombogenicity of the remaining appendage pouch is a mat-
ter of major concern [31, 81••, 82]. In a previous non-
randomized study that compared efficacy of several methods
of LAA closure, TEE reveled a remnant LAA in 26% of
patients. Importantly, 12% of these patients had suffered
strokes in the lapse from the operation to the time when
TEE was performed, despite none having clots in the remnant
LAA [83]. In early studies on excision of the LAA after sta-
pling, additional sutures were necessary to repair tears [84,
85], and similar complications with tears needing repair have
also been reported more recently in the LAAOS-II trial [86].
Furthermore, intuitively, an irregular endocardial surface after
suture (Fig. 1a) may be more thrombogenic than a smoother
surface observable after epicardial stapling (Fig. 1b) and after
epicardial clips (Fig. 1c) or snaring (Fig. 1d). Assuming the
size of the remaining pouch is important for its
thrombogenicity, perioperative TEE could serve for assessing
its size, and perioperatively, limit the size of the pouch for
example to less than 1 cm, by performing an additional suture
or stapler line, or placing an additional clip when needed.
Conclusion
Several studies support a beneficial effect of LAA closure
during surgery, but evidence is not yet sufficient to support
closure of the LAA systematically in addition to heart surgery,
Fig. 1 View of the endocardial
surface of the left atrium, after
LAA exclusion with: suture
marked with white arrows, the
black arrows show the circumflex
coronary artery a, epicardial
stapling (b), clips (c), or
epicardial snoring, with a black
arrow showing the endocardial
surface (d). LAA left atrium
appendage. (Figure 1a is
reproduced from Aoyagi S. et al.
Heart, Lung and Circulation,
2017.26:413–15, with permission
from Elsevier; [87].) (Figure 1c is
kindly provided by AtriCure Inc.)
(Figure 1d is reproduced from
Bartus K et al. Circ Arrhythm
Electrophysiol. 2014;7:764–767,
with permission; [88])
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to protect against thromboembolisms related to AF. Hence,
there is a need for randomized studies to provide the evidence
of stroke protection and, furthermore, comparing different
methods for closure of the LAA in terms of arrhythmogenic
impact. Such studies should address how to manage the po-
tential thromboembolic problem of a remaining pouch after
LAA closure, to elucidate what is the optimal management of
the LAA during surgery.
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